BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21879467)

  • 1. The characteristics of osteoporotic fractures in the region of Bialystok (BOS-2). The application of the WHO algorithm, FRAX®BMI and FRAX®BMD assessment tools to determine patients for intervention.
    Badurski J; Jeziernicka E; Dobreńko A; Nowak N; Daniluk S; Rybaczuk M; Wiśniowiecka M
    Endokrynol Pol; 2011; 62(4):290-8. PubMed ID: 21879467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of osteoporotic fractures in the group of woman over 50 years of age--comparison of tools FRAX BMD versus FRAX BMI].
    Strugala C; Sobala W; Szubert Z; Hanke W
    Med Pr; 2013; 64(3):327-33. PubMed ID: 24261246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fracture risk prediction in outpatients from Krakow Region using FRAX tool versus fracture risk in 11-year follow-up.
    Czerwiński E; Borowy P; Kumorek A; Amarowicz J; Górkiewicz M; Milert A
    Ortop Traumatol Rehabil; 2013; 15(6):617-28. PubMed ID: 24662908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
    Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
    BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Kajita E; Kagamimori S; Kagawa Y; Yoneshima H
    Osteoporos Int; 2011 Dec; 22(12):3037-45. PubMed ID: 21279504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort.
    González-Macías J; Marin F; Vila J; Díez-Pérez A
    Bone; 2012 Jan; 50(1):373-7. PubMed ID: 22129640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort.
    Azagra R; Roca G; Encabo G; Aguyé A; Zwart M; Güell S; Puchol N; Gene E; Casado E; Sancho P; Solà S; Torán P; Iglesias M; Gisbert MC; López-Expósito F; Pujol-Salud J; Fernandez-Hermida Y; Puente A; Rosàs M; Bou V; Antón JJ; Lansdberg G; Martín-Sánchez JC; Díez-Pérez A; Prieto-Alhambra D
    BMC Musculoskelet Disord; 2012 Oct; 13():204. PubMed ID: 23088223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.
    Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD;
    Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
    Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FRAX or fiction: determining optimal screening strategies for treatment of osteoporosis in residents in long-term care facilities.
    Greenspan SL; Perera S; Nace D; Zukowski KS; Ferchak MA; Lee CJ; Nayak S; Resnick NM
    J Am Geriatr Soc; 2012 Apr; 60(4):684-90. PubMed ID: 22316237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
    Yu R; Leung J; Woo J
    J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of densitometry and fracture risk assessment tool FRAX in making therapeutic decisions in osteoporosis--a study on female patients of university of medical sciences endocrinology outpatient clinic].
    Ignaszak-Szczepaniak M; Dytfeld J; Michalak M; Gowin E; Horst-Sikorska W
    Ginekol Pol; 2009 Jun; 80(6):424-31. PubMed ID: 19642598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is It Possible to Increase the Clinical Effectiveness of the Fracture Risk Assessment Tool in Osteopenia Patients by Taking Into Account Bone Mineral Density Values?
    Park JS; Lee J; Park YS
    J Clin Densitom; 2016; 19(3):340-5. PubMed ID: 26822485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study.
    Dagan N; Cohen-Stavi C; Leventer-Roberts M; Balicer RD
    BMJ; 2017 Jan; 356():i6755. PubMed ID: 28104610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model.
    Lopez Gavilanez E; Johansson H; McCloskey E; Harvey NC; Segale Bajana A; Marriott Blum D; Navarro Grijalva M; Diaz Curiel M; Kanis JA
    Arch Osteoporos; 2019 Aug; 14(1):93. PubMed ID: 31440846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of hip fracture in Brazil and the development of a FRAX model.
    Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
    Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study.
    Rubin KH; Abrahamsen B; Friis-Holmberg T; Hjelmborg JV; Bech M; Hermann AP; Barkmann R; Glüer CC; Brixen K
    Bone; 2013 Sep; 56(1):16-22. PubMed ID: 23669650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of FRAX to characterise fracture risk in Poland.
    Czerwinski E; Kanis JA; Osieleniec J; Kumorek A; Milert A; Johansson H; McCloskey EV; Gorkiewicz M
    Osteoporos Int; 2011 Sep; 22(9):2507-12. PubMed ID: 21127840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture Risk Assessment With FRAX Using Real-World Data in a Population-Based Cohort From Israel.
    Goldshtein I; Gerber Y; Ish-Shalom S; Leshno M
    Am J Epidemiol; 2018 Jan; 187(1):94-102. PubMed ID: 28520844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the FRAX model for hip fracture predictions in the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE).
    Sund R; Honkanen R; Johansson H; Odén A; McCloskey E; Kanis J; Kröger H
    Calcif Tissue Int; 2014 Jul; 95(1):39-45. PubMed ID: 24792689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.